SYN-COLL (Palmitoyl Tripeptide-5)

SYN-COLL is palmitoyl tripeptide-5, identified by PubChem as palmitoyl-lysyl-valyl-lysine (C33H65N5O5, MW 611.9, CAS 623172-55-4) — a palmitoylated Lys-Val-Lys tripeptide.

Its design rationale is more specific than most cosmetic peptides. Rather than being a fragment of collagen itself, the KVK motif is intended to mimic thrombospondin-1, a matrix protein that activates latent TGF-β. TGF-β is a principal driver of collagen synthesis, and most of it in tissue exists in a latent, inactive complex. The proposition is therefore not to add collagen or to signal for more TGF-β, but to switch on TGF-β that is already present.

That is a coherent and interesting mechanism. It is also worth noting the flip side: TGF-β activation is the same axis implicated in fibrosis and scarring. A mechanism that usefully increases dermal collagen is not automatically benign at higher exposure, and published characterisation of that boundary in skin is limited.

The limiting factor for every topical peptide is delivery. Peptides are hydrophilic and relatively large, while the stratum corneum is a lipophilic barrier built to exclude exactly such molecules. A peptide that performs well in a fibroblast culture has not thereby been shown to reach fibroblasts through intact skin. Reviews of cosmeceutical peptides identify this permeability gap — not receptor pharmacology — as the principal open problem, and note that formulation strategies such as oil-in-water and water-in-oil-in-water emulsions are used to try to close it with uncertain success.

Independent clinical evidence isolating this ingredient was not located; support is largely manufacturer-associated. The proposed mechanism — activating latent TGF-β — sits on the same pathway involved in fibrosis and hypertrophic scarring, and the dose and exposure boundary between desirable collagen support and undesirable fibrotic signalling has not been well characterised in published skin work.

Palmitoyl tripeptide-5 is C33H65N5O5, MW 611.9, CAS 623172-55-4, PubChem CID 11950477. The two lysine residues give the peptide portion a strong positive charge at skin pH, which the palmitoyl chain offsets for barrier partitioning.